Monkeypox is a smallpox-like disease that was first detected 50 years ago in the Democratic Republic of the Congo. New cases of community transmis1
The analysis of two cohorts from the United Kingdom and Catalonia concluded that at least one dose of vaccine does not increase the risk of suffering1
The biotechnological pharmaceutical company HIPRA has received authorization from the Spanish Agencyfor Medicines and Health Products (AEMPS) to sta1
The COVID-19 pandemic has emphasised the importance of vaccination. Every year the public faces the influenza virus, which causes more than 200,000 d1
The study, led by CIBERES, included the participation of IDIBAPS and was published in the Journal of Internal Medicine.
Since the start of the vaccination campaign, there has been a significant reduction in severe cases of COVID-19. Nevertheless, some fully vaccinated1
This week the vaccine began to be administered to the first volunteers participating in Phase I/IIa of the trial at the Hospital Trueta in Girona and1
Some questions we make ourselves about vaccination in this pandemic time
HIPRA (Amer, Girona) is looking for volunteers aged between 18 and 39 who have not received any COVID-19 vaccine and who have not had the infection,1
Interview with Dr. Manel Juan, head of the Immunology Service
